Bio Digital Europe: Market Status and
Trends and Future Outlook 2000 - 2010

Table of Contents

1. Executive Summary
1.1  Competing Technologies
1.2  Diagnostic Opportunities
1.3  Microarray (Biochip) Applications
1.4  Lab on a Chip Applications
1.5  Market Segments by User Category
          1.5.1 Key players: Role of Clinical Trial and Big Pharma
          1.5.2 Big Pharma Company Profiles

2. Industry Overview
2.1  Enabling Technology
2.2  Evolution of the Biochip
2.3  Current Tests
2.4  Driving Forces in the Industry
2.5  Government Grants and Development Programs
          2.5.1  Germany
          2.5.2  United Kingdom
2.6  Companies Categorized by Application Area
2.7  Timeline for Adoption
          2.7.1  Barriers
          2.7.2  Regulatory Issues
          2.7.3  Patent Battles

3. Interrelated Business
3.1  Partner/Strategic Alliance in the Industry

4. Market Analysis
4.1  Bioinformatics: A Driver
4.2  Health Care: Industry Trends

5. Industry and Market Demand for DNA Chip
5.1  Market Categories
5.2  Market Demand
         5.2.1  Market Size of DNA chip Market Categories
         5.2.2 Change in Biochip Product Mixture between 2000 and 2010
         5.2.3  Market Growth for DNA Chip by Market Segment 2000-2010
         5.2.4  Growth of DNA Chip Market 2000-2010
         5.2.5  Business Strategies for Biochip Suppliers
         5.2.6  Biochip Market Share in 2000 including All Market Segments
         5.2.7  Biochip Market Share in 2010
         5.2.8  Percent of Market by Segment in 2000 and 2010
         5.2.9  Lab on a Chip Market Share in 2010
5.3  Timeline for Biochip Adoption
5.4  Technology Suppliers and Strategies
5.5  DNA Chip Manufacturing Technologies

6. Biochip Suppliers for Business Partner
6.1  Scanning and Detection Technology Vendors (Profiled in this Report)
6.2  Non-DNA Based Chip: Proteomics Vendors
6.3  Lab-On-Chip Vendors
6.4  Bioinformatics Tools

7. Summary of Opportunities

8. Biochip Industry Company Profiles: Europe
Antisoma (UK)
BASF Lync Bioscience AG (Germany)
Bioleads AG (Germany)
Biolytix (Switzerland)
BioMax Informatics GmbH (Germany)
BioRobotics (UK)
Biovation Ltd. (UK)
CellZome GmbH (Germany)
Chem Ovation (UK)
Clondiag (Germany)
Compugen (Israel)
CyBio AG (Germany)
DeCode (Iceland)
De Novo Pharmaceuticals Ltd. (UK)
DeveloGen AG (Germany)
Discovery Technologies AG (Switzerland)
Epigenomics AG (Germany)
Evotec Biosystems AG (Germany)
FeBiT-Ferrarius Biotechnology
GmbH (Germany)
Gemini Genomics (UK) Ltd.
Gene Alliance (Germany)
GENE BIO (Switzerland)
GeneData AG (Switzerland)
GeneScan Europe AG (Germany)
Geneva Proteomics (Switzerland)
Genomatix Software GmbH (Germany)
Genome Pharmaceuticals Corporation AG (Germany)
GeoPrint Bioinformatics (Germany)
Genset (France)
Gesim GmbH (Germany)
Graffinity Pharmaceutical Design
GmbH (Germany)
Greiner Labortechnik GmbH (Germany)
Interactiva (Germany)
Inpharmatica (UK)
Isenselt (Bremen)
Biobase AG (Germany)
Amersham Pharmacia Biotech (Sweden)
LaVision Biotec GmbH (Germany)
Lion BioScience (Germany)
Memorec Stoffel (Germany)
MorhphoSys AG (Germany)
MWG-Biotech AG (Germany)
Oxford GlycoScience (UK)
Prionics (Switzerland)
PamGene B.V. (Netherlands)
Proteosys: Molecular Systems
Analysis (Germany)
ProteoMetrics, LLC (UK)
PerkinElmer Wallac (Germany)
Quantifoil Micro Tools GmbH (Germany)
Qiagen NV (Germany)
Spotfire (Sweden)
Synomics (UK)
TopLab GmbH (Germany)
Tecan AG (Switzerland)
Upstream Solutions GmbH (Switzerland)
Zeptoses (Switzerland)

Press Release
Order